News and Press Releases

Quell Therapeutics to Participate at Upcoming Healthcare Investor Conferences

6 November 2024– London, UK – Quell Therapeutics Ltd (“Quell”), a world leader in developing engineered T-regulatory (Treg) cell therapies for serious medical conditions driven by the immune system, announces...

Category: Biotechnology
Posted: November 6, 2024

Quell Therapeutics Ltd, Translation & Innovation Hub, 84 Wood Lane, London, W12 OBZ